Henry Schein delivered a solid Q1 2025 performance with $3.17 billion in revenue and a net income of $110 million. Non-GAAP EPS reached $1.15, supported by gains in medical distribution and specialty products, despite restructuring costs and a decline in dental equipment sales.
Total revenue reached $3.17 billion, nearly flat YoY due to currency headwinds.
GAAP EPS grew to $0.88 while non-GAAP EPS rose to $1.15.
Medical distribution saw strong 3.0% growth in constant currency, driven by home solutions and acquisitions.
The company recorded $25 million in restructuring costs aiming for up to $100 million in annualized savings.
Henry Schein maintained its 2025 outlook with expectations for moderate growth in non-GAAP EPS and EBITDA, supported by operational improvements and expansion in core segments.
Visualization of income flow from segment revenue to net income